2017
DOI: 10.7860/jcdr/2017/22801.9557
|View full text |Cite
|
Sign up to set email alerts
|

Extramedullary Solitary Plasmacytoma: Demonstrating the Role of 18F-FDG PET Imaging

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

1
14
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(15 citation statements)
references
References 12 publications
1
14
0
Order By: Relevance
“…[14] We have also recently reported EMPs in duodenum, pancreas, and ovary in a single patient. [2] Similar to our case, Vailati et al . have also reported plasmacytoma of the thyroid as an initial presentation of MM.…”
supporting
confidence: 89%
See 1 more Smart Citation
“…[14] We have also recently reported EMPs in duodenum, pancreas, and ovary in a single patient. [2] Similar to our case, Vailati et al . have also reported plasmacytoma of the thyroid as an initial presentation of MM.…”
supporting
confidence: 89%
“…With the aid of the present case and our previously reported cases of plasmacytomas involving rare sites such as frontal bone, duodenum, pancreatic head, and ovary, we aim to enrich the knowledge of our readers about the unusual presentations and rare locations of extramedullary plasmacytomas (EMPs). [23]…”
mentioning
confidence: 99%
“…On 18 FDG PET/CT images, the maxSUV difference in 18 FDG uptake can distinguish between benign and malignant lesions in many cases. [1,2,7,8,17] MRI is also a good tool to differentiate primary or metastatic malignant spine tumors from benign compression fractures. However, occasionally, this distinction is difficult.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, MRI is advised as a routine staging procedure during the workup of EMP 11. 18FDG-PET/CT examines the whole body in a faster and single study, with a sensitivity of 96% and a specificity of 77% 12. In fact, PET/CT is mandatory for confirming a diagnosis of EMP according to the updated 2017 International Myeloma Working Group guidelines 13.…”
Section: Discussionmentioning
confidence: 99%